GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Days Sales Outstanding

JCR Pharmaceuticals Co (TSE:4552) Days Sales Outstanding : 177.72 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Days Sales Outstanding?

JCR Pharmaceuticals Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円18,397 Mil. JCR Pharmaceuticals Co's Revenue for the three months ended in Dec. 2023 was 円9,446 Mil. Hence, JCR Pharmaceuticals Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 177.72.

The historical rank and industry rank for JCR Pharmaceuticals Co's Days Sales Outstanding or its related term are showing as below:

TSE:4552' s Days Sales Outstanding Range Over the Past 10 Years
Min: 84.92   Med: 109.99   Max: 142
Current: 121.99

During the past 13 years, JCR Pharmaceuticals Co's highest Days Sales Outstanding was 142.00. The lowest was 84.92. And the median was 109.99.

TSE:4552's Days Sales Outstanding is ranked worse than
83.77% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs TSE:4552: 121.99

JCR Pharmaceuticals Co's Days Sales Outstanding increased from Dec. 2022 (80.56) to Dec. 2023 (177.72).


JCR Pharmaceuticals Co Days Sales Outstanding Historical Data

The historical data trend for JCR Pharmaceuticals Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Days Sales Outstanding Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123.81 98.03 84.92 142.00 94.82

JCR Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.30 100.50 112.45 177.72 162.30

Competitive Comparison of JCR Pharmaceuticals Co's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Days Sales Outstanding falls into.



JCR Pharmaceuticals Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

JCR Pharmaceuticals Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (11137 + 0) / 1 ) / 42871*365
=11137 / 42871*365
=94.82

JCR Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (20514 + 16280) / 2 ) / 9446*365 / 4
=18397 / 9446*365 / 4
=177.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JCR Pharmaceuticals Co  (TSE:4552) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


JCR Pharmaceuticals Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines